For instance, recently it was demonstrated that the blocking of programmed death-ligand in tumour cells to recruit the adaptive immune system is important to potentiate the recruitment of the innate immune system (through the disruption of CD47–SIRPα interaction) to target cancer cells51. The gene discussed is CD47; the disease is cancer.